Abstract:
Piperazine derivatives have the general formula (I) wherein R1, R2 and R3 are the same or different and represent hydrogen, C1-C6-alkyl, C3-C7 alkoxy alkyl, aryl, aryl-C1-C6-alkyl or aryloxy-C1-C6-alkyl, R4 represents C1-C4-alkoxy substituted completely or for its major part with fluorine, R5 represents aryl, heteroaryl, aryl-C1-C4-alkyl, heteroaryl-C1-C4-alkyl, diaryl-C1-C4-alkyl, heteroaryl-aryl-C1-C4-alkyl or di-heteroaryl-C1-C4-alkyl. Said derivatives and salts thereof are new compositions for the treatment and prophylaxy of diseases due to circulation troubles.
Abstract:
New inclusion complexes of omeprazol with cyclodextrines, characterized by their stomach protection activity. They present a high storage stability and therefore are particularly useful in drugs.
Abstract:
Use of oxirancarboxylic acids of formula (I), whereby R1, R2, R3, Y and n have the meanings indicated in the claims for the prevention and/or treatment of illnesses which are associated with an increased cholesterol and/or triglyceride concentration.
Abstract:
Compositions having the general formula (I) B3RuX3 wherein B is a mononucleous or polynucleous basic heterocycle having one or a plurality of nitrogen atoms and X is chlorine or bromine, having a tumor inhibiting activity and thus being usable in chemiotherapy for the treatment of cancer.
Abstract:
Amino compounds having the formula (I), wherein the substituents have the meaning given in the description of the invention, and salts thereof are new compounds having an intense stomach protective effect.
Abstract:
6-Aryl-3[2H]pyridazinones of formula (I), wherein one of the substituents R1 or R2 denotes methoxy and the other denotes (C2-C5)alkoxy or (C3-C5)alkenyloxy and X denotes oxygen or sulfur, and their pharmaco logically acceptable salts with bases, are suitable for use as a bronchospasmolytic or cardiotonic agent. Processes for the preparation of the compounds and appropriate medicaments are described.
Abstract:
Metal complexes of the general formula I wherein M denotes titanium, zirconium or hafnium, R denotes hydrogen, C1-C8-alkyl or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C1-C4-alkyl, C1-C4-alkoxy of trifluoromethyl, R denotes C1-C8-alkyl, or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C1-C4-alkyl, C1-C4-alkoxy or trifluoromethyl, R denotes hydrogen or phenyl, R denotes C1-C18-alkyl, which can be substituted by hydroxyl, C1-C3-alkylamino or alkali metal sulfonato groups, or denotes C5-C8-cycloalkyl, which can be substituted by C1-C5-alkyl groups, hydroxyl or alkali metal sulfonato groups, X denotes fluorine, chlorine or bromine, m denotes the number 0 or 1, but does not denote 0 if R denotes hydrogen, and n denotes the number 0 or 1, and, if a radical R contains an amino group, hydrohalides thereof, exhibit a very good cytostatic activity, coupled with low toxicity. They are suitable for the production of medicaments having an antineoplastic action.
Abstract:
The torpedo-shaped suppository (12) with incorporated buffer wick (13) is packed between two bands presenting deep deformations (1, 2). The back ends (5, 6) of the two welded bands (1, 2) are folded back at right angles in the area (3) of the reception cavities (9, 10) of the suppositories, and the surface formed by the two folded edges receives a closure sheet (8).
Abstract:
Acides carboxyliques de phénylalkyloxirane de formule générale I:$(8,)$où R1 représente un atome d'hydrogène, un atome d'halogène, un groupe alkyl inférieur, un groupe alkoxy inférieur ou un groupe trifluorométhyl, R2 possède l'une des représentations de R1, A est une liaison simple, un groupe -CH(R6)-CH(R7)- , un groupe CH(R6)-CH(R7)-CH(R8)- ou un groupe -CH(R6)-CH(R7)-CH(R8)-CH(R9)-, R5 représente un atome d'hydrogène ou un groupe alkyl inférieur et l'un des substituants R3, R4, R6, R7, R8 ou R9 représente un groupe alkyl inférieur et les autres représentent des atomes d'hydrogène, et les sels des acides carboxyliques sont de nouveaux composés ayant une action hypoglycémique. Un procédé pour leur préparation et un nouveau procédé de préparation des produits intermédiaires sont décrits.
Abstract:
Compounds having the general formula (I) (BHn)m[RuX3+nm-q-r(OH)r(BHp)3-nm+q]1+p+q wherein B is a mononucleous or polynucleous basic heterocycle containing one or a plurality of nitrogen atoms, X is chlorine or bromine, m is 1 or 2, n is 1 or 2, the sum of n + m not exceeding 3, p is 0 or 1, but not 1 if n is 1, q is 0 or 1 but not 1 if p is 1 and r is 0 or 1, presenting a tumor inhibiting activity and thus useable in chemiotherapy for the treatment of cancer.